Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
6-month placebo-controlled CPC mouthrinse study for plaque and gingivitis prevention
NL-OMON33187Not yet recruiting
- Sponsor
- Academic Centre for Dentistry in Amsterdam
- Start
- Jun 2009
- Modality
- Small Molecules, Conventional Liposomes → Liposomes → Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Trial of cetylpyridinium chloride in gingivitis (2 arms), sponsored by Academic Centre for Dentistry in Amsterdam. Primary endpoint: Quigley and Hein plaque index. Planned start Jun 2009; status: not yet recruiting.
02
Drugs
cetylpyridinium chloride
03
Conditions
gingivitis
Beyond the preview
Go deeper on NL-OMON33187.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON33187.